Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Endocannabinoids in nervous system health and disease: the big picture in a nutshell.

Skaper SD, Di Marzo V.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3193-200. doi: 10.1098/rstb.2012.0313.

2.

Endogenous cannabinoids revisited: a biochemistry perspective.

Fonseca BM, Costa MA, Almada M, Correia-da-Silva G, Teixeira NA.

Prostaglandins Other Lipid Mediat. 2013 Apr-May;102-103:13-30. doi: 10.1016/j.prostaglandins.2013.02.002. Epub 2013 Mar 7. Review.

PMID:
23474290
3.

Mixed signals: cannabinoid system offers new therapeutic possibilities as well as challenges.

Shekhar C.

Chem Biol. 2011 May 27;18(5):553-4. doi: 10.1016/j.chembiol.2011.05.004. No abstract available.

4.

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.

Pertwee RG.

Addict Biol. 2008 Jun;13(2):147-59. doi: 10.1111/j.1369-1600.2008.00108.x. Review.

PMID:
18482430
5.

An Introduction to the Endogenous Cannabinoid System.

Lu HC, Mackie K.

Biol Psychiatry. 2016 Apr 1;79(7):516-25. doi: 10.1016/j.biopsych.2015.07.028. Epub 2015 Oct 30. Review.

6.

Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.

Nader J, Rapino C, Gennequin B, Chavant F, Francheteau M, Makriyannis A, Duranti A, Maccarrone M, Solinas M, Thiriet N.

Neuropharmacology. 2014 Dec;87:214-21. doi: 10.1016/j.neuropharm.2014.03.014. Epub 2014 Apr 5.

7.

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

Iannotti FA, Di Marzo V, Petrosino S.

Prog Lipid Res. 2016 Apr;62:107-28. doi: 10.1016/j.plipres.2016.02.002. Epub 2016 Mar 7. Review.

PMID:
26965148
8.

The endocannabinoid system and pain.

Guindon J, Hohmann AG.

CNS Neurol Disord Drug Targets. 2009 Dec;8(6):403-21. Review.

9.

Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.

Basavarajappa BS, Nixon RA, Arancio O.

Mini Rev Med Chem. 2009 Apr;9(4):448-62. Review.

10.

Why do cannabinoid receptors have more than one endogenous ligand?

Di Marzo V, De Petrocellis L.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3216-28. doi: 10.1098/rstb.2011.0382. Review.

11.

Neuroscience. Stout guards of the central nervous system.

Mechoulam R, Lichtman AH.

Science. 2003 Oct 3;302(5642):65-7.

PMID:
14526067
12.

Endocannabinoid system and pain: an introduction.

Burston JJ, Woodhams SG.

Proc Nutr Soc. 2014 Feb;73(1):106-17. doi: 10.1017/S0029665113003650. Epub 2013 Oct 22. Review.

PMID:
24148358
13.

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.

Turcotte C, Chouinard F, Lefebvre JS, Flamand N.

J Leukoc Biol. 2015 Jun;97(6):1049-70. doi: 10.1189/jlb.3RU0115-021R. Epub 2015 Apr 15. Review.

PMID:
25877930
14.

The endocannabinoid system: physiology and pharmacology.

Rodríguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M.

Alcohol Alcohol. 2005 Jan-Feb;40(1):2-14. Epub 2004 Nov 18. Review.

PMID:
15550444
15.

Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

Wiley JL, Walentiny DM, Wright MJ Jr, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE.

Eur J Pharmacol. 2014 Aug 15;737:97-105. doi: 10.1016/j.ejphar.2014.05.013. Epub 2014 May 22.

16.

Age-dependent plasticity in endocannabinoid modulation of pain processing through postnatal development.

Kwok CH, Devonshire IM, Imraish A, Greenspon CM, Lockwood S, Fielden C, Cooper A, Woodhams S, Sarmad S, Ortori CA, Barrett DA, Kendall D, Bennett AJ, Chapman V, Hathway GJ.

Pain. 2017 Nov;158(11):2222-2232. doi: 10.1097/j.pain.0000000000001027.

17.

Anandamide in primary sensory neurons: too much of a good thing?

Sousa-Valente J, Varga A, Ananthan K, Khajuria A, Nagy I.

Eur J Neurosci. 2014 Feb;39(3):409-18. doi: 10.1111/ejn.12467. Review.

PMID:
24494681
18.

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.

Pertwee RG.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3353-63. doi: 10.1098/rstb.2011.0381. Review.

19.

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids.

Puighermanal E, Busquets-Garcia A, Maldonado R, Ozaita A.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3254-63. doi: 10.1098/rstb.2011.0384. Review.

20.

Supplemental Content

Support Center